Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
1176
DELISTED
Terminix Global Holdings, Inc.
TMX
| $12.6M | 0.02% |
370,073
-257,148
| -41% | -$8.96M |
|
1177
PUT
Align Technology
ALGN
$11.3B
| $12.6M | 0.02% |
50,000
+45,000
| +900% | +$11.6M |
|
1178
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $12.5M | 0.02% |
76,900
+71,900
| +1,438% | +$11.7M |
|
1179
Strategy Inc
MSTR
$48.7B
| $12.5M | 0.02% |
970,320
+276,050
| +40% | +$3.72M |
|
1180
Vanguard S&P 500 ETF
VOO
$1.02T
| $12.5M | 0.02% |
51,655
+15,828
| +44% | +$3.97M |
|
1181
COPT Defense Properties
CDP
$4.25B
| $12.5M | 0.02% |
483,842
-1,319,773
| -73% | -$35M |
|
1182
KRONOS Worldwide
KRO
$1B
| $12.5M | 0.02% |
552,637
+440,234
| +392% | +$11M |
|
1183
Liberty Latin America Class C
LILAK
$1.64B
| $12.5M | 0.02% |
764,240
+368,923
| +93% | +$6.79M |
|
|
CRC
1184
DELISTED
California Resources Corporation
CRC
| $12.5M | 0.02% |
727,722
+690,503
| +1,855% | +$13M |
|
1185
Quest Diagnostics
DGX
$26.9B
| $12.5M | 0.02% |
124,357
-645,405
| -84% | -$66.1M |
|
1186
Acuity Brands
AYI
$10.1B
| $12.5M | 0.02% |
89,494
-172,762
| -66% | -$26.6M |
|
|
PVLA
1187
Palvella Therapeutics
PVLA
$2.1B
| $12.4M | 0.02% |
22,801
+14,054
| +161% | +$8.7M |
|
1188
CALL
Stryker
SYK
$126B
| $12.4M | 0.02% |
77,300
+67,300
| +673% | +$10.8M |
|
|
ECHO
1189
EchoStar
ECHO
$24.8B
| $12.4M | 0.02% |
290,305
-115,991
| -29% | -$5.52M |
|
1190
Eagle Materials
EXP
$6.27B
| $12.4M | 0.02% |
120,344
-66,255
| -36% | -$7.14M |
|
1191
Morningstar
MORN
$8.16B
| $12.4M | 0.02% |
129,829
-37,624
| -22% | -$3.62M |
|
1192
Compañía de Minas Buenaventura
BVN
$8.94B
| $12.3M | 0.02% |
810,662
-450,851
| -36% | -$6.83M |
|
1193
Andersons Inc
ANDE
$2.23B
| $12.3M | 0.02% |
372,474
-17,438
| -4% | -$591K |
|
1194
LXP Industrial Trust
LXP
$3.6B
| $12.3M | 0.02% |
312,867
+91,046
| +41% | +$3.87M |
|
1195
Marcus Corp
MCS
$953M
| $12.3M | 0.02% |
404,236
+94,196
| +30% | +$2.59M |
|
1196
Agree Realty
ADC
$9.28B
| $12.2M | 0.02% |
+254,908
| New | +$12.2M |
|
1197
CALL
DexCom
DXCM
$34.4B
| $12.2M | 0.02% |
660,000
+20,000
| +3% | +$296K |
|
1198
Grupo Aeroportuario Centro Norte
OMAB
$4.97B
| $12.2M | 0.02% |
309,894
+16,878
| +6% | +$690K |
|
1199
Comfort Systems
FIX
$56.7B
| $12.2M | 0.02% |
295,713
-45,843
| -13% | -$1.93M |
|
|
MNTA
1200
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $12.1M | 0.02% |
669,149
-100,543
| -13% | -$1.68M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.